Modified immune cells target severe lupus in groundbreaking trial
NCT ID NCT06333483
Summary
This early study is testing a new treatment for severe lupus that hasn't responded to other therapies. Doctors take a patient's own immune cells, modify them to target lupus-causing cells, and return them to the body. The study will check if this approach is safe and shows early signs of helping control the disease in up to 18 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Addenbrookes Hospital
RECRUITINGCambridge, CB2 0QQ, United Kingdom
Contact Email: •••••@•••••
-
Great Ormond Street Hospital
RECRUITINGLondon, WC1N 3JH, United Kingdom
Contact Email: •••••@•••••
-
Hospital Universitari Vall Hebrón
RECRUITINGBarcelona, 08035, Spain
Contact Email: •••••@•••••
-
Hospital Universitari i Politecnic La Fe
RECRUITINGValencia, 106046026, Spain
Contact Email: •••••@•••••
-
Manchester Royal Infirmary, Manchester University NHS Foundation Trust,
RECRUITINGManchester, M13 9WL, United Kingdom
Contact Email: •••••@•••••
-
University College London Hospitals NHS Foundation Trust
RECRUITINGLondon, NW1 2PG, United Kingdom
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.